They found that the levels of serum WFDC2 were generally elevated in lung cancer patients (Table 1), making it easy to distinguish the lung cancer patients from healthy controls (Nagy et al., 2014; Liu et al., 2013; Iwahori et al., 2012). Here, WFDC2 is linked to lung cancer.